RELATING TO MEDICAL CANNABIS.
Summary
Defines "waiting room" within a medical cannabis retail dispensing location and clarifies public access to the waiting room. Adds or clarifies requirements for the dispensary program related to signage, permitted types of manufactured cannabis products, supervision of certain personnel while onsite at retail dispensing locations or medical cannabis production centers, annual reporting requirements for DOH, and DOH's education and training program. Clarifies penalties for violations. Establishes the medical cannabis cultivation site registry and imposes fees. Amends the uses of the medical cannabis registry and regulation special fund. Prohibits the cultivation, production, manufacture, possession, distribution, handling, or dispensation of medical cannabis except by specific persons or entities. Restricts the number of qualifying patients who may use a grow site to twenty, unless an exemption is obtained from DOH. Prohibits the use or receipt of cannabis as compensation for acting as a primary caregiver to a qualifying patient. Establishes annual reporting requirements for DOH regarding the medical cannabis patient registry program. Requires a report from DBEDT. Makes various housekeeping amendments. Effective 6/30/3000. (HD2)
Bill status
passed
4 of 5 stages cleared
Introduction
Jan 2023
Committee Review
Mar 2023
Senate Passage
Mar 2023
House Passage
Mar 2023
Governor
Introduced Jan 20, 2023
Last action Mar 24, 2023
Floor votes · Senate Mar 7, 2023 · House Mar 17, 2023
How they voted
24–0
Passed · 1 other
Total votes 25
Mar 7, 2023
D
Democratic23
95% Yea
R
Republican2
100% Yea
Vote distribution
All Yea
All Nay
Mixed
No data
Full legislative history
Actions timeline
Total actions
26
Key actions
10
Committee
14
Mar 24, 2023
Committee
Report adopted. referred to the committee(s) on FIN as amended in HD 2 with Representative(s) Hussey-Burdick voting aye with reservations; none voting no (0) and Representative(s) Ilagan excused (1).
lower
Mar 24, 2023
Committee
Reported from CPC (Stand. Com. Rep. No. 1541) as amended in HD 2, recommending referral to FIN.
lower
Mar 21, 2023
Lower · Passed
The committee on CPC recommend that the measure be PASSED, WITH AMENDMENTS. The votes were as follows: 11 Ayes: Representative(s) Nakashima, Sayama, Belatti, Hashem, Gates, Lowen, Onishi, Tam, Pierick; Ayes with reservations: Representative(s) Amato, Hussey-Burdick; Noes: none; and Excused: none.
lower
Mar 17, 2023
Committee
Reported from HLT (Stand. Com. Rep. No. 1311) as amended in HD 1, recommending passage on Second Reading and referral to CPC.
lower
Mar 17, 2023
House · Passed
House Vote: pass (50-0-1)
house
Mar 15, 2023
Lower · Passed
The committee on HLT recommend that the measure be PASSED, WITH AMENDMENTS. The votes were as follows: 7 Ayes: Representative(s) Belatti, Takenouchi, Amato, Ilagan, Mizuno, Nishimoto, Garcia; Ayes with reservations: none; Noes: none; and 1 Excused: Representative(s) Kobayashi.
lower
Mar 9, 2023
Committee
Referred to HLT, CPC, FIN, referral sheet 17
lower
Mar 7, 2023
Introduced
Received from Senate (Sen. Com. No. 319) in amended form (SD 1).
lower
Mar 7, 2023
Upper · Passed
Report adopted; Passed Third Reading. Ayes, 24; Aye(s) with reservations: none . Noes, 0 (none). Excused, 1 (Senator(s) Fukunaga). Transmitted to House.
upper
Mar 3, 2023
Upper · Passed
The committee(s) on WAM recommend(s) that the measure be PASSED, UNAMENDED. The votes in WAM were as follows: 12 Aye(s): Senator(s) Dela Cruz, Keith-Agaran, Aquino, DeCoite, Inouye, Kanuha, Kidani, Kim, Lee, Moriwaki, Shimabukuro, Wakai; Aye(s) with reservations: none ; 0 No(es): none; and 1 Excused: Senator(s) Fevella.
upper
Mar 3, 2023
Upper · Passed
The committee(s) on JDC recommend(s) that the measure be PASSED, UNAMENDED. The votes in JDC were as follows: 5 Aye(s): Senator(s) Rhoads, Gabbard, Elefante, San Buenaventura, Awa; Aye(s) with reservations: none ; 0 No(es): none; and 0 Excused: none.
upper
Feb 28, 2023
Upper · Passed
The committee(s) on JDC/WAM will hold a public decision making on 03-03-23 10:00AM; Conference Room 211 & Videoconference.
upper
Feb 17, 2023
Committee
Reported from HHS/CPN (Stand. Com. Rep. No. 562) with recommendation of passage on Second Reading, as amended (SD 1) and referral to JDC/WAM.
upper
Feb 15, 2023
Upper · Passed
The committee(s) on HHS recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in HHS were as follows: 4 Aye(s): Senator(s) San Buenaventura, Aquino, Shimabukuro, Awa; Aye(s) with reservations: none ; 0 No(es): none; and 1 Excused: Senator(s) Moriwaki.
upper
Feb 15, 2023
Upper · Passed
The committee(s) on CPN recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in CPN were as follows: 5 Aye(s): Senator(s) Keohokalole, Fukunaga, McKelvey, Richards, Awa; Aye(s) with reservations: none ; 0 No(es): none; and 0 Excused: none.
upper
Feb 10, 2023
Upper · Passed
The committee(s) on HHS/CPN added the measure to the public hearing scheduled on 02-15-23 9:30AM; CR 229 & Videoconference.
upper
Jan 27, 2023
Committee
Referred to HHS/CPN, JDC/WAM.
upper
Jan 20, 2023
Introduced
Introduced.
upper
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Jarrett Keohokalole
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about SB 962
Scope: HI
Hi! I can help you understand SB 962. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline